>>Where is the receptor for TrpRS? If it's intracellular, then bathing tissue in the protein probably won't be effecteve.<<
The companies developing RNAi-based treatments for AMD (Acuity, RNAI, and ALNY) would seem to face the same problem, and it has not dissuaded them from trying.
“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”